Hwa Jung Kim
Associate Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (20)
Year:
2027
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Purpose: The decision for treatment after neoadjuvant chemoradiotherapy (nCRT) in rectal cancer is intricately linked to tumor response and clinical parameters. This study was designed to elucidate determinants influencing treatment decisions for good responders to nCRT, while concurrently evaluating the ramifications of modifications in magnetic resonance imaging (MRI) tumor response evaluation protocols.Methods: A survey was constructed with 5 cases of good responder after nCRT based on the magnetic resonance–based tumor regression grade (mrTRG) criteria. A total of 35 colorectal surgeons in Korea participated in the survey via email, and they were introduced to 2 discrete MRI-based tumor response evaluation methodologies: the conventional mrTRG and an emergent complete response (CR)/non-CR classification system. Surgeons were directed to select between total mesorectal excision, local excision, or a watch and wait strategy.Results: Treatment decisions varied significantly (P<0.01), as gradually more clinical information was provided with mrTRG. The paradigm shift from mrTRG to CR/non-CR evaluation criterion instigated the highest alteration in decision (P<0.01). Even comparing with other sets of information, decision change with different tumor response assessment (i.e., mrTRG vs. CR/non-CR) was statistically significant (P<0.01). Three particular cases consistently displayed a declining predilection for total mesorectal excision, favoring a more pronounced inclination towards watch and wait strategy or local excision. Nonetheless, the magnitude of these decisional shifts oscillated depending on the specific endoscopic imagery present.Conclusion: Our current findings underscore the significant role of tumor response assessment methods in shaping treatment decisions for rectal cancer patients who respond well to nCRT. This highlights the need for clear and accurate tools to interpret MRI results.
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Collaborators (26)
Hak Hee Kim
Professor
Asan Medical Center
In Ja Park
Professor
Asan Medical Center
Jonggi Choi
Associate Professor
Asan Medical Center
Ju Young Kim
Chief Medical Officer
-
Hanjong Ahn
University of Ulsan College of Medicine
Kee Don Choi
Professor
Asan Medical Center
suhyeon Ha
Asan Medical Center
Yong Sik Yoon
Professor
Asan Medical Center
Young Il Kim
Assistant professor
Asan Medical Center
Sang Hyub Lee
Seoul National University Hospital
Do Hoon Kim
University of Ulsan College of Medicine
Woohyung Lee
Assistant professor
Asan Medical Center
Seong Ho Park
University of Ulsan College of Medicine
Min Soo Cho
Associate professor
Asan Medical Center
In Woong Han
Surgeon/ Assistant professor
Samsung Medical Center
Chan-Young Jung
Assistant Professor
Asan Medical Center
Jeong Hoon Lee
Asan Medical Center
Woo Hyun Paik
Seoul National University Hospital
Ho-Seong Han
Professor
Seoul National University Hospital
Young Seok Kim
The Catholic University of Korea
Nobuyuki Nishizawa
Junior Associate Professor
Kitasato University
Segyeong Joo
Professor
University of Ulsan College of Medicine
Woo Je Lee
University of Ulsan College of Medicine
Seo Young Park
Korea University
Sung Shin
University of Ulsan College of Medicine
Kee Wook Jung
Clinical Professor
Asan Medical Center
Make your next move.
Prepare your application
Review drafts before you send them.